ID   HAP1 ANO6 (-) 1
AC   CVCL_RX74
SY   HZGHC002956c003; ANO6 knockout cell line 20bp deletion in exon 5; KO-T16F
DR   cancercelllines; CVCL_RX74
DR   Horizon_Discovery; HZGHC002956c003
DR   Wikidata; Q54872637
RX   PubMed=29463790;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 25240; ANO6.
CC   Sequence variation: Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 11
//
RX   PubMed=29463790; DOI=10.1038/s41419-018-0373-8;
RA   Ousingsawat J., Wanitchakool P., Schreiber R., Kunzelmann K.;
RT   "Contribution of TMEM16F to pyroptotic cell death.";
RL   Cell Death Dis. 9:300.1-300.11(2018).
//